Important milestone for cancer patients in Norway:
Åslaug Helland, oncologist and group leader in the department will lead a new center for clinical treatment research that receives major funding from The Research Council of Norway and the Norwegian Cancer Society:
The Research Council of Norway and the Norwegian Cancer Society have allocated 128 mill. NOK for a Centre for Clincial Treatment Research for treatment of cancer.
"This funding is an important contribution to Norwegian cancer research and will ensure that more patients will be included into clinical trials. The aim is new and better treatment alternatives for hard-to-treat cancers. We will develop next generation diagnostics and treatment for increased overall survival and quality of life for cancer patients all over Norway" says Åslaug Helland, leader of the centre.
Conferral ceremony 30. September 2021
Tine Alver and Zhi Zhao receiving their PhD ceremonial diplomas
Tine Alver and Zhi Zhao from our department, received their PhD ceremonial diplomas in the University's ceremonial hall, the Aula, on 30. September 2021.
Dyrbekk APH, Warsame AA, Suhrke P, Ludahl MO, Moe JO, Eide IJZ, Lund-Iversen M, Brustugun OT(2023) "Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer" Diagn Pathol, 18(1), 70 DOI 10.1186/s13000-023-01357-1, PubMed 37237384
Potdar S, Ianevski F, Ianevski A, Tanoli Z, Wennerberg K, Seashore-Ludlow B, Kallioniemi O, Östling P, Aittokallio T, Saarela J(2023) Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data Nucleic Acids Res(in press) DOI 10.1093/nar/gkad390, PubMed 37178002
Otte M, Stachelscheid J, Glaß M, Wahnschaffe L, Jiang Q, Lone W, Ianevski A, Aittokallio T, Iqbal J, Hallek M, Hüttelmaier S, Schrader A, Braun T, Herling M(2023) The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL Cancers (Basel), 15(9) DOI 10.3390/cancers15092527, PubMed 37173993